Benefits and Challenges of Successfully Implementing the Direct to Patient Model – 1

The attendee will be able to:

1. Describe two (2) benefits each for the clinical site, sponsor and patient of a direct to patient trial
2. Identify at least two (2) risks for sponsors and develop an effective mitigation strategy for these risks
3. Identify two (2) late stage customization strategies that can support delivery of medication closer to the patient thus minimizing waste

Login

Please log in using your GCSG credentials.

Lost your password?

Login

Please log in using your GCSG credentials.

Lost your password?